AvantGuard, Inc., previously known as Halomine Inc., is making significant strides in the realm of antimicrobial solutions with its cutting-edge technology. The company focuses on providing long-term pathogen protection against viruses, bacteria, and fungi/mold, effectively addressing significant challenges in sectors like healthcare, food processing, and hospitality.
Founded in 2018 as a spin-out from Cornell University, AvantGuard capitalizes on its proprietary combinations of specialty molecules and polymers that maintain chlorine efficacy on surfaces for up to a month. This breakthrough surpasses the 15-minute protection typical of standard disinfectants, offering substantial economic and safety benefits, given the over $100B annual cost of infections and food-borne illnesses globally.
The company's credibility is bolstered by partnerships with renowned institutions and thoughtful licensing agreements with Cornell and Auburn University. Recently, it secured a $2.85M Seed Round on 11 May 2023, backed by investors including SOSV, Red Bear Angels, Blue Ledge Capital, and Launch NY, signaling strong potential and investor confidence.